Rice Hall James & Associates LLC Has $22.37 Million Stake in Teleflex Incorporated (NYSE:TFX)
Rice Hall James & Associates LLC boosted its stake in Teleflex Incorporated (NYSE:TFX) by 24.9% during the second quarter, Holdings Channel reports. The fund owned 107,681 shares of the medical technology company’s stock after buying an additional 21,461 shares during the period. Teleflex comprises about 1.0% of Rice Hall James & Associates LLC’s investment portfolio, making the stock its 26th largest position. Rice Hall James & Associates LLC’s holdings in Teleflex were worth $22,372,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Rafferty Asset Management LLC purchased a new position in shares of Teleflex during the first quarter valued at approximately $877,000. Creative Planning increased its position in shares of Teleflex by 69.5% in the second quarter. Creative Planning now owns 3,828 shares of the medical technology company’s stock valued at $795,000 after buying an additional 1,569 shares during the last quarter. UBS Asset Management Americas Inc. increased its position in shares of Teleflex by 118.9% in the fourth quarter. UBS Asset Management Americas Inc. now owns 72,560 shares of the medical technology company’s stock valued at $11,692,000 after buying an additional 39,419 shares during the last quarter. Sit Investment Associates Inc. increased its position in shares of Teleflex by 180.0% in the first quarter. Sit Investment Associates Inc. now owns 2,800 shares of the medical technology company’s stock valued at $542,000 after buying an additional 1,800 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC purchased a new position in shares of Teleflex during the first quarter valued at approximately $2,619,000. 93.02% of the stock is currently owned by institutional investors.
Teleflex Incorporated (TFX) opened at 204.00 on Friday. The stock has a market capitalization of $9.19 billion, a P/E ratio of 39.01 and a beta of 1.05. The firm’s 50-day moving average is $209.38 and its 200-day moving average is $196.62. Teleflex Incorporated has a 12 month low of $136.53 and a 12 month high of $217.97.
Teleflex (NYSE:TFX) last released its earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.13. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The business had revenue of $528.60 million during the quarter, compared to the consensus estimate of $518.98 million. During the same period last year, the company earned $1.89 earnings per share. The business’s revenue for the quarter was up 11.6% compared to the same quarter last year. On average, equities analysts expect that Teleflex Incorporated will post $8.28 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Stockholders of record on Tuesday, August 15th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, August 11th. This represents a $1.36 annualized dividend and a dividend yield of 0.67%. Teleflex’s dividend payout ratio (DPR) is 26.00%.
A number of research analysts have issued reports on TFX shares. Barclays PLC reissued a “buy” rating on shares of Teleflex in a research report on Monday, June 26th. Deutsche Bank AG reissued a “buy” rating and set a $238.00 price objective (up from $220.00) on shares of Teleflex in a research report on Wednesday. Needham & Company LLC reissued a “buy” rating on shares of Teleflex in a research report on Friday, August 4th. Zacks Investment Research raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $228.00 price objective on the stock in a research report on Friday, June 23rd. Finally, Jefferies Group LLC reissued a “buy” rating and set a $230.00 price objective on shares of Teleflex in a research report on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $228.00.
In other Teleflex news, Director Gretchen R. Haggerty bought 1,000 shares of the firm’s stock in a transaction dated Wednesday, June 21st. The stock was acquired at an average cost of $203.82 per share, for a total transaction of $203,820.00. Following the completion of the transaction, the director now owns 1,760 shares in the company, valued at $358,723.20. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $208.41, for a total value of $41,682.00. Following the sale, the director now owns 8,080 shares of the company’s stock, valued at $1,683,952.80. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,300 shares of company stock valued at $1,643,975. Corporate insiders own 2.39% of the company’s stock.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.